Cyclophosphamide and Abametapir: Interaction Details
- Cyclophosphamide
- CytoxanFrindovyx
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Cyclophosphamide and Abametapir interaction:
Abametapir
We don't have a drug information page for Abametapir because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Abametapir? Ask a pharmacist, free →
Cyclophosphamide
- Cytoxan
- Frindovyx
What Happens When You Take Cyclophosphamide With Abametapir
What can happen when they are taken together (rated Major)
Increased exposure of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Once abametapir has been applied, do not administer CYP2B6 substrates for 2 weeks. When this cannot be done, abametapir itself should not be used.1
The Cyclophosphamide and Abametapir Interaction, Explained
Abametapir is a lotion used to treat head lice. Cyclophosphamide (Cytoxan) is a medicine used for cancer and some immune conditions. Your body has to switch on cyclophosphamide using a liver enzyme called before it can work. Abametapir can slow that enzyme for up to about 2 weeks after you use it. That means more of the inactive form of cyclophosphamide may stay in your body, and possibly less of the active form gets made. This could change how well your treatment works or how you feel on it.
This concern is based on how the drugs work, not on studies in patients. Still, it is taken seriously. Your care team can easily choose another lice treatment, so please tell them before using abametapir.
Mechanism: Abametapir (and its ) inhibits , an effect that may persist for about 2 weeks after topical application. Cyclophosphamide is a that relies largely on CYP2B6 (with and contributing) for 4-hydroxylation to its active alkylating species.
- Direction: Increased exposure () of parent cyclophosphamide is expected. Reduced formation of 4-hydroxycyclophosphamide may follow, with potential loss of or altered toxicity.
- Magnitude/onset: Not quantified; onset unspecified.
- Evidence: Theoretical, based on in vitro data.
- Severity: Major.
- Management: Avoid CYP2B6 within 2 weeks after abametapir application. If this is not feasible, avoid abametapir and use an alternative pediculicide.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Cyclophosphamide and Abametapir Interact
The likely mechanism
of -mediated by abametapir
How to Manage the Cyclophosphamide and Abametapir Interaction
The documented approach is to keep these two medicines apart in time:
- Your care team typically avoids giving cyclophosphamide within 2 weeks after abametapir is applied.
- If that timing is not possible (for example, your cyclophosphamide schedule cannot wait), the usual choice is to skip abametapir and use a different head lice treatment.
What you can do: Keep taking cyclophosphamide exactly as prescribed. Before anyone in your care uses abametapir, tell your pharmacist and your oncology or prescribing team so they can pick the safest lice treatment for you.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Cyclophosphamide or Abametapir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Cyclophosphamide and Abametapir: Common Questions
How serious is the Cyclophosphamide and Abametapir interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Cyclophosphamide and Abametapir interaction managed?
The documented approach is to keep these two medicines apart in time: Your care team typically avoids giving cyclophosphamide within 2 weeks after abametapir is applied. If that timing is not possible (for example, your cyclophosphamide schedule cannot wait), the usual choice is to skip abametapir and use a different head lice treatment. What you can do: Keep taking cyclophosphamide exactly as pre… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Cyclophosphamide and Abametapir Interaction
Ask in your own words about taking Cyclophosphamide and Abametapir together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: XEGLYZE(TM) topical lotion, abametapir topical lotion. Dr Reddy’s Laboratories Inc (per FDA), Princeton, NJ, 2020. DailyMed
Other Serious Interactions of Cyclophosphamide and Abametapir
Also serious with Abametapir
Also serious with Cyclophosphamide
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Abametapir
- Green TeaModerate
- CannabisModerate
- YohimbeModerate
- Black TeaModerate
- Pu-erh TeaModerate
- AdrafinilModerate
- Cannabidiol (CBD)Moderate
- Cannabinol (CBN)Moderate
- + 14 more
With Cyclophosphamide
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Vitamin CModerate
- Vitamin EModerate
- + 216 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.